The CC ligand chemokine family members CCL17/CCL22 predict the survival and response to immune checkpoint blockade therapy of patients with head and neck squamous cell carcinoma.
Curr Probl Cancer
; 46(6): 100896, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36167005
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chemokines, CC
/
Head and Neck Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Curr Probl Cancer
Year:
2022
Document type:
Article
Country of publication: